Experienced in High Cholesterol

Dr. Sammy Elmariah

Cardiology
Interventional Cardiology Program
400 Parnassus Ave # 5, 
San Francisco,, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth
Experienced in High Cholesterol
Interventional Cardiology Program
400 Parnassus Ave # 5, 
San Francisco,, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Sammy Elmariah is a Cardiologist in San Francisco,, California. Dr. Elmariah is rated as an Experienced provider by MediFind in the treatment of High Cholesterol. His top areas of expertise are Aortic Valve Stenosis, Mitral Stenosis, Patent Foramen Ovale, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

His clinical research consists of co-authoring 195 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of High Cholesterol.

Specialties
Cardiology
Licenses
Internal Medicine in CA
Hospital Affiliations
Ucsf Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 1 Less Insurance Carrier -

Locations

Interventional Cardiology Program
400 Parnassus Ave # 5, San Francisco,, CA 94143
Other Locations
Heart Valve Disease Clinic
535 Mission Bay Blvd S, San Francisco,, CA 94143

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Tricuspid Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System and Optimal Medical Therapy (OMT) Compared to OMT Alone in Patients With Tricuspid Regurgitation
A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Tricuspid Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System and Optimal Medical Therapy (OMT) Compared to OMT Alone in Patients With Tricuspid Regurgitation
Enrollment Status: Recruiting
Publish Date: September 22, 2025
Intervention Type: Device, Drug
Study Phase: Not Applicable
Percutaneous MitraClip Device or Surgical Mitral Valve REpair in PAtients With PrImaRy MItral Regurgitation Who Are Candidates for Surgery (REPAIR MR)
Percutaneous MitraClip Device or Surgical Mitral Valve REpair in PAtients With PrImaRy MItral Regurgitation Who Are Candidates for Surgery (REPAIR MR)
Enrollment Status: Active_not_recruiting
Publish Date: November 12, 2025
Intervention Type: Device, Procedure
Study Phase: Not Applicable
Edwards EVOQUE Transcatheter Tricuspid Valve Replacement: Pivotal Clinical Investigation of Safety and Clinical Efficacy Using a Novel Device
Edwards EVOQUE Transcatheter Tricuspid Valve Replacement: Pivotal Clinical Investigation of Safety and Clinical Efficacy Using a Novel Device
Enrollment Status: Active_not_recruiting
Publish Date: October 09, 2025
Intervention Type: Device, Drug
Study Phase: Not Applicable
Edwards EVOQUE Tricuspid Valve Replacement: Investigation of Safety and Clinical Efficacy After Replacement of Tricuspid Valve With Transcatheter Device
Edwards EVOQUE Tricuspid Valve Replacement: Investigation of Safety and Clinical Efficacy After Replacement of Tricuspid Valve With Transcatheter Device
Enrollment Status: Active_not_recruiting
Publish Date: August 15, 2025
Intervention Type: Device
Study Phase: Not Applicable
The OPTIMIZE Trial to Assess the Procedural and Clinical Value of the Svelte IDS and RX Sirolimus Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions in a Randomized Study
The OPTIMIZE Trial to Assess the Procedural and Clinical Value of the Svelte IDS and RX Sirolimus Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions in a Randomized Study
Enrollment Status: Terminated
Publish Date: March 23, 2023
Intervention Type: Device
Study Phase: Not Applicable
A pragmatiC sTrategy to Promote actIVity and Enhance Quality of Life AFTER Transcatheter Aortic Valve Replacement (ACTIVE AFTER TAVR): A Pilot Study
A pragmatiC sTrategy to Promote actIVity and Enhance Quality of Life AFTER Transcatheter Aortic Valve Replacement (ACTIVE AFTER TAVR): A Pilot Study
Enrollment Status: Completed
Publish Date: April 01, 2021
Intervention Type: Behavioral
Study Phase: Not Applicable
View 5 Less Clinical Trials

195 Total Publications

From Damage Control to Damage Prevention: Early TAVR and Cardiac Remodeling.
From Damage Control to Damage Prevention: Early TAVR and Cardiac Remodeling.
Journal: Journal of the American College of Cardiology
Published: September 18, 2025
Similar Doctors
Elite in High Cholesterol
Dr. Sotirios Tsimikas
Cardiology
Elite in High Cholesterol
Dr. Sotirios Tsimikas
Cardiology

Office

9434 Medical Center Dr, 
La Jolla,, CA 
 (448.1 miles away)
858-657-8530
Languages Spoken:
English
See accepted insurances

Sotirios Tsimikas is a Cardiologist in La Jolla,, California. Dr. Tsimikas is rated as an Elite provider by MediFind in the treatment of High Cholesterol. His top areas of expertise are High Cholesterol, Apolipoprotein C2 Deficiency, Familial Lipoprotein Lipase Deficiency, Percutaneous Coronary Intervention (PCI), and Stent Placement.

Pam Taub
Distinguished in High Cholesterol
Dr. Pam Taub
Cardiology
Distinguished in High Cholesterol
Dr. Pam Taub
Cardiology

Office

9434 Medical Center Dr, 
La Jolla, CA 
 (448.1 miles away)
858-657-8530
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Pam Taub is a Cardiologist in La Jolla, California. Dr. Taub is rated as a Distinguished provider by MediFind in the treatment of High Cholesterol. Her top areas of expertise are Postural Orthostatic Tachycardia Syndrome (POTS), Heart Failure, Familial Dysautonomia, High Cholesterol, and Heart Transplant.

Distinguished in High Cholesterol
Dr. Mehran Moussavian
Cardiology
Distinguished in High Cholesterol
Dr. Mehran Moussavian
Cardiology

San Diego Imaging-Chula Vista LLC

765 Medical Center Ct, 
Chula Vista, CA 
 (469.5 miles away)
619-616-2100
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Mehran Moussavian is a Cardiologist in Chula Vista, California. Dr. Moussavian is rated as a Distinguished provider by MediFind in the treatment of High Cholesterol. His top areas of expertise are Varicose Veins, Nasal Flaring, Familial Neurocardiogenic Syncope, Angioplasty, and Transcatheter Aortic Valve Replacement (TAVR).

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Elmariah's expertise for a condition
ConditionClose
View All 32 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile